Skip to main content
. 2016 Feb 11;6:20882. doi: 10.1038/srep20882

Figure 3. Prognostic relevance between 5hmC level and glioma patients by Kaplan-Meier analysis.

Figure 3

(A,B) Kaplan-Meier survival analysis of glioma patients when all samples were divided into 7 groups (A) based on 5hmC scores 0, 1, 2, 3, 4, 6 and 9, or two groups (B) based on 5hmC scores 0–2 and 3–9. (C) Prognostic relevance between pathological grades and glioma patients was examined by Kaplan-Meier analysis. (D–H) Relevance between 5hmC level and patient survival within diffuse astrocytomas (D); oligodendrogliomas (E); anaplastic astrocytomas (F); anaplastic oligodendrogliomas (G) and glioblastoma multiforme (H) was tested by Kaplan-Meier analysis.